triumph 1 trial retatrutide TRIUMPH-1 Shows Potential for As a Treatment for Obesity Finished 18 month Triumph 1

Though peptides in general are gaining traction across a range of therapeutic frontiers, from rare diseases to neurodegenerative conditions such as Alzheimers, the rise of GLP-1s as a blockbuster therapy for chronic weight management has redefined the field of peptide manufacturing

Injection Timing and Location Experiment with your injection schedule

Because retatrutide is not yet licensed for clinical use in the UK, these timelines are drawn from trial data rather than real-world clinical experience

Side effects are minimal or absent for the majority

Metabolic Health Status Participants with type 2 diabetes showed remarkable weight loss alongside significant improvements in glycemic control